In-vitro Diagnostics Market Size to exceed $95bn by 2025

In-vitro Diagnostics Market size is set to exceed USD 95 billion by 2025; according to a new research report by Global Market Insights.
 

Rapidly growing demand for automated laboratory machines and equipment primarily will drive in-vitro diagnostics (IVD) industry growth. Adoption of advanced technologies in developed countries has led to modifications in the medical diagnostic machinery and equipment. Also, developed economies have focused their attempts on R&D activities to manufacture automated laboratory equipment for accurate disease detection. Rising implementation of advanced diagnostic machinery should augment in vitro diagnostics business growth. Moreover, specific regulations laid by European Diagnostic Clusters Alliance (EDCA), on the manufacturers of IVD tools to meet patient’s safety will prove beneficial for the industry growth.

 

 Request Sample Buy NowInquiry Before Buying


 

Growing preference towards personalized medication for the treatment of several chronic disorders will render positive impact on IVD market. Benefits delivered by personalized treatment and medicines including optimal dosing, accurate and target treatment along with early intervention will surge its demand over the coming years. Additionally, extensive usage of in vitro diagnostics to develop new therapies to treat different chronic diseases on molecular level is expected to further propel business growth. However, unfavorable reimbursement scenario may restrict in-vitro diagnostics business growth during the analysis timeframe.
 

In-vitro diagnostics Market

Get more details on this report - Request Free Sample PDF
 

Product segment was valued over 17 billion in 2018 and will witness lucrative growth during the analysis period. Product improvizations and high utilization of reagents and kits in diagnosis of viral infections and other hormonal disorders including hyperthyroidism will favor segmental growth. Moreover, focus of manufacturers on developing superior quality reagents for accurate disease diagnosis will accelerate the demand for IVD products, thereby, should upsurge the business growth.
 

Clinical chemistry segment accounted for around 20% revenue share in 2018 and will show substantial CAGR by 2025. Wide usage of clinical chemistry in development of novel therapies to eradicate the gene-level diseases including cystic fibrosis, sickle cell anemia and Huntington’s disease will boost segmental growth over the analysis period.
 

Infectious diseases segment was valued more than 15 billion in 2018 and is expected to experience momentous growth during analysis period. Segment growth is attributed to rising prevalence of salmonella infections that typically develops due to infection in the intestinal tract. Increasing demand for in-vitro diagnostics in effective diagnosis of infectious diseases will favor segmental growth.
 

Laboratories segment accounted for over 29% revenue share in 2018 owing to growing number of well-equipped laboratories delivering superior quality diagnostic services. Surge in the number of laboratories that strive to provide accurate diagnostic decisions will increase the demand for advanced and innovative technologies within the diagnostic devices, thereby, augmenting in-vitro diagnostics business growth.
 

Browse key industry insights spread across 244 pages with 342 market data tables & 10 figures & charts from the report, “In-vitro Diagnostics Market Size By Type (Product [Reagents & Kits, Instruments], Service [Software, Testing Services]), By Technology (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics) By End-user (Hospitals, Point of Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/in-vitro-diagnostics-market
 

North America in-vitro diagnostics market is expected to witness over 5% CAGR. Increasing burden of viral infection and chronic diseases have surged the demand for in-vitro diagnostics in the region. Furthermore, presence of Medicare and Medicaid facilities for effective health management and awareness among people regrading early and reliable disease diagnosis should foster the business growth.
 

Some of the eminent business players operating in in-vitro diagnostics market include Qiagen, Becton Dickinson, Abbott, Cephied, Johnson & Johnson, BioRad, Grifols, Danaher, Siemens, Luminex, Roche Diagnostics, Thermo Fisher Scientific, Sorin, and BioMerieux. Business players focus on various strategic initiatives to improve their revenue share and strengthen market position. For instance, in March 2018, Danaher acquired Integrated DNA Technologies. This strategic acquisition enabled company to broaden its customer base and gain more revenue. Furthermore, in May 2018, Abbott introduced Afinion 2 analyzer, a rapid test system for diabetes management to enhance its existing product portfolio and capitalize over market opportunities.
 

Inquiry Before BuyingRequest Sample
 

In-vitro diagnostics market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

In-vitro Diagnostics Market By Type, 2014-2025 (USD Million)

  • Product
    • Reagents & kits
    • Instruments
  • Service
    • Software
    • Testing services

In-vitro Diagnostics Market By Technology, 2014-2025 (USD Million)

  • Clinical Chemistry 
  • Immunoassay/Immunochemistry 
  • Molecular Diagnostics
  • Hematology 
  • Microbiology 
  • Coagulation and Hemostasis 
  • Urinalysis 
  • Others

In-vitro Diagnostics Market By Application, 2014-2025 (USD Million)

  • Oncology 
  • Infectious Diseases
  • Diabetes 
  • Cardiology 
  • Nephrology 
  • Autoimmune Diseases 
  • Drug Testing/Pharmacogenomics 
  • Others

In-vitro Diagnostics Market, By End-user (USD million)

  • Hospitals 
  • Point of Care Testing 
  • Laboratories 
  • Academic Institutes 
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East Asia & Africa
    • Saudi Arabia
    • South Africa
    • UAE

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree